It has been known that there is a clinically distinctive aggressive variant prostate cancer (AVPC), presenting with low-serum PSA, neuroendocrine small cell or ductal histology, which frequently metastasizes to visceral organs and rapidly develops castration resistance. The gene discussed is KLK3; the disease is prostate carcinoma.